戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 cells of a patient with a t(2;11)(q22.1;q21) chromosomal translocation.
2 factor is associated with risk of a specific chromosomal translocation.
3  multiple myeloma due to a recurrent t(4;14) chromosomal translocation.
4 ffects in ALL with the t(12;21)/(ETV6-RUNX1) chromosomal translocation.
5 (PML)/RARalpha, which is generated in APL by chromosomal translocation.
6 f PAX5 in cells with and without the t(8;21) chromosomal translocation.
7 s formed as the result of a disease-specific chromosomal translocation.
8 me expansion, chromosomal rearrangement, and chromosomal translocation.
9 R1- (EWS) fusion genes that are derived from chromosomal translocation.
10 ociated with a balanced t(1;11)(q42.1;q14.3) chromosomal translocation.
11 ous end-joining (Alt-NHEJ) events, including chromosomal translocations.
12 nst DNA damage, and reduces the frequency of chromosomal translocations.
13 ements, including deletions, inversions, and chromosomal translocations.
14  for the formation of AID-dependent Igh-cMyc chromosomal translocations.
15 territories favors DSB formation, leading to chromosomal translocations.
16 d with mutations, altered gene expression or chromosomal translocations.
17 2 (FGFR2) fusion proteins (FFs) generated by chromosomal translocations.
18 rrangement and the role of ATM in preventing chromosomal translocations.
19 ed due to involvement in leukemia-associated chromosomal translocations.
20 ollicular lymphoma is one of the most common chromosomal translocations.
21 mplicated in joining DSBs found in oncogenic chromosomal translocations.
22 repair activity, but at the cost of frequent chromosomal translocations.
23  from GC B cells and frequently involves MYC chromosomal translocations.
24 quence identity that can potentially mediate chromosomal translocations.
25 tion of signal ends as potentially oncogenic chromosomal translocations.
26 reater potential than SIT, but depended upon chromosomal translocations.
27 yndrome (DS-ALL) patients, lacking recurring chromosomal translocations.
28 e NHEJ, an error-prone pathway implicated in chromosomal translocations.
29 s that can serve as substrates for oncogenic chromosomal translocations.
30 type marginal zone (MZ) lymphomas because of chromosomal translocations.
31 s, rather than breakpoints in trans, forming chromosomal translocations.
32 dily detected circulating disease or canonic chromosomal translocations.
33 onsequences including off-target editing and chromosomal translocations.
34 icated in cancer-associated gene fusions and chromosomal translocations.
35  hub of RAG-mediated V(D)J recombination and chromosomal translocations.
36 arranged in a number of different cancers by chromosomal translocations.
37 stic leukemia through its involvement in the chromosomal translocation 1;19 and consequent expression
38 ia 1 (DISC1) gene is disrupted by a balanced chromosomal translocation (1; 11) (q42; q14.3) in a Scot
39                                Recently, the chromosomal translocation 3;21, leading to the fusion ge
40                                              Chromosomal translocation 8;21 is found in 40% of the FA
41 riants in NR2F2 including a de novo balanced chromosomal translocation, a de novo substitution disrup
42 a snoRNA overexpressed as a consequence of a chromosomal translocation, a potent driving force of the
43 ich premalignant B cells carrying a t(14;18) chromosomal translocation accumulate additional genetic
44 ant tumors of soft tissue and bone sharing a chromosomal translocation affecting the EWS locus.
45                                              Chromosomal translocations affecting mixed lineage leuke
46 ange in gene sequences and thus suggest that chromosomal translocations alone may play an underapprec
47 dly develop thymic lymphomas bearing complex chromosomal translocations, amplifications and deletions
48 M-dependent DNA damage responses, leading to chromosomal translocation and defective G(2)/M checkpoin
49 ful platform for understanding the effect of chromosomal translocation and for the development of new
50 iple myeloma (MM) as a result of the t(4;14) chromosomal translocation and in a broad variety of othe
51    Two of these driving loci are linked by a chromosomal translocation and thus constitute a novel ty
52 in originally identified as the product of a chromosomal translocation and which associates with both
53                                              Chromosomal translocations and activation of the fibrobl
54 Ls that respond poorly to current therapies, chromosomal translocations and amplification lead to con
55 re involved in recurrent leukemia-associated chromosomal translocations and are key regulators of cel
56 ps with an alternative breakpoint region for chromosomal translocations and contains a GC-specific no
57 llegitimate recombination that can result in chromosomal translocations and deletions.
58  promotes lymphocyte malignancies by causing chromosomal translocations and DNA deletions at cancer g
59 ressive pro-B cell lymphomas bearing complex chromosomal translocations and gene amplifications invol
60               Of 268 cases without recurrent chromosomal translocations and high hyperdiploidy, repre
61 neage leukemia (MLL) fusion genes arise from chromosomal translocations and induce acute myeloid leuk
62 ia/lymphoma 1 (TCL1) oncogene is a target of chromosomal translocations and inversions at 14q31.2, an
63 ic development and its dysregulation through chromosomal translocations and loss-of-function mutation
64  genomic instability by initiating oncogenic chromosomal translocations and mutations involved in the
65  used for antibody diversification can cause chromosomal translocations and oncogenic mutations.
66  data define PARP1 as a critical mediator of chromosomal translocations and raise the possibility tha
67 in GSI-resistant human tumor cell lines with chromosomal translocations and rearrangements in Notch g
68 anscription factors associated with balanced chromosomal translocations and salivary gland tumors.
69 homologous end joining, which contributes to chromosomal translocations and telomere fusions, but the
70  promiscuously damages oncogenes, leading to chromosomal translocations and tumorigenesis.
71 int mutations, amplifications/deletions, and chromosomal translocations, and how these aberrant event
72                                              Chromosomal translocations are a genomic hallmark of man
73                                              Chromosomal translocations are a hallmark of cancer.
74                                              Chromosomal translocations are a hallmark of hematopoiet
75                                              Chromosomal translocations are a hallmark of leukemia/ly
76                                              Chromosomal translocations are a major source of genetic
77             Chimeric oncoproteins created by chromosomal translocations are among the most common gen
78                                    Recurrent chromosomal translocations are characteristic features o
79                                              Chromosomal translocations are common contributors to ma
80                                      Whereas chromosomal translocations are common pathogenetic event
81                                              Chromosomal translocations are frequently associated wit
82                   MLL is a common target for chromosomal translocations associated with acute leukemi
83 ) is a proto-oncogene frequently involved in chromosomal translocations associated with acute leukemi
84      The t(8;21) is one of the most frequent chromosomal translocations associated with acute myeloid
85 g it suitable for discovering and cataloging chromosomal translocations associated with specific grou
86 ndicated that T-DNA insertion lines can have chromosomal translocations associated with the T-DNA ins
87 NHEJ at dysfunctional telomeres, and hinders chromosomal translocations at non-telomeric loci.
88 ), is the premier model of cancer-associated chromosomal translocations because it is the only transl
89 ressive soft tissue tumor characterized by a chromosomal translocation between chromosome 18 and X, g
90   EWS-ATF1, the fusion product of a balanced chromosomal translocation between chromosomes 22 and 12,
91  identification of the genes associated with chromosomal translocation breakpoints has fundamentally
92     We examine a set of clinically important chromosomal translocation breakpoints that occur at long
93 was not seen in conjunction with established chromosomal translocations but 6 (12%) cases had high hy
94 only for the repair of pathologic DSBs as in chromosomal translocations, but also for the repair of p
95 t of ESC-based cellular and animal models of chromosomal translocation by CRISPR/Cas9 provides a powe
96 nd frequency of DNA damage in the genesis of chromosomal translocations by measuring these parameters
97 reases class switch recombination as well as chromosomal translocation byproducts.
98             Here, we show that site-specific chromosomal translocations can be generated in mouse emb
99                                    Recurrent chromosomal translocations can drive oncogenesis, but ho
100 210(BCR-ABL), the fusion product of a (9;22) chromosomal translocation causative for chronic myeloid
101                                              Chromosomal translocations causing deregulated c-MYC exp
102                               Tumor-specific chromosomal translocations, characteristic findings in s
103 ription factor c-Myc, e.g. caused by t(8;14) chromosomal translocation commonly found in Burkitt lymp
104                                        These chromosomal translocations commonly result in MLL fusion
105 osa, we determined that dosage variation and chromosomal translocations consistent with homoeologous
106 leotide substitutions, insertions/deletions, chromosomal translocations, copy number abnormalities, a
107     Over 80% of aRMSs are characterized by a chromosomal translocation-derived fusion transcription f
108 tly driven by genetic abnormalities, such as chromosomal translocations directly involving the MYC lo
109                                            A chromosomal translocation disrupting human MBOAT1 result
110 netic-epigenetic interplay at breakpoints of chromosomal translocations disrupting CG-rich loci, we q
111                                              Chromosomal translocations disrupting MLL generate MLL-f
112  by a single amino acid substitution or by a chromosomal translocation [e.g., t(8;21)], is linked to
113                                              Chromosomal translocations encode oncogenic fusion prote
114  Many sarcomas and leukemias carry nonrandom chromosomal translocations encoding tumor-specific mutan
115 DNA sequencing data, we developed Fusion And Chromosomal Translocation Enumeration and Recovery Algor
116              Using as models three different chromosomal translocations-ETV6-RUNX1 (TEL-AML1), BCR-AB
117 nserved (Chorisporeae) or were reshuffled by chromosomal translocations (Euclidieae).
118 hese domains would be lost or disrupted by a chromosomal translocation event after amino acid 597, wh
119    The FUS and EWSR1 genes are also prone to chromosomal translocation events, which result in aberra
120 om DNA-PKcs (5A/5A) B cells reveal increased chromosomal translocations, extensive use of distal swit
121 nalysis identified a pattern of paired intra-chromosomal translocations flanking focal amplifications
122 vement of interchromosomal LCRs in recurrent chromosomal translocation formation, we performed comput
123                                          The chromosomal translocations found in acute myelogenous le
124  AID and increased somatic hypermutation and chromosomal translocation frequency to the Igh locus and
125 OZ (MYST3, KAT6A) is the target of recurrent chromosomal translocations fusing the MOZ gene to CBP, p
126 ypes via various direct mechanisms including chromosomal translocations, gene amplification or deleti
127 essive soft-tissue malignancies that express chromosomal translocation-generated fusion genes, SS18-S
128 and can lead to rDNA transcriptional arrest, chromosomal translocations, genomic losses, and cell dea
129 show that well-established cancer-associated chromosomal translocations give rise to fusion circRNAs
130                                 The t(10;11) chromosomal translocation gives rise to the CALM-AF10 fu
131                                        While chromosomal translocations have a fundamental role in th
132 two defined loci can produce stable balanced chromosomal translocations, however, a single engineered
133   The lack of cellular and animal models for chromosomal translocations, however, has hampered our ab
134            CML iPSCs showed a unique complex chromosomal translocation identified in marrow sample wh
135  contribute to oncogenic activation, when in chromosomal translocations Ig enhancer elements and onco
136  PARP1 protein expression strongly repressed chromosomal translocations, implying that PARP1 is essen
137                  Here we find that a t(5:12) chromosomal translocation in a family manifesting neurod
138 transcriptionally as a result of the t(4;14) chromosomal translocation in a subset of patients with M
139 s a fusion oncoprotein generated by the 2;13 chromosomal translocation in alveolar rhabdomyosarcoma (
140 ression, suggesting that its deregulation by chromosomal translocation in BL leads to miR-28 suppress
141 ncogenic fusion gene EWS-WT1 is the defining chromosomal translocation in desmoplastic small round-ce
142 ic myelogenous leukemia (CML) results from a chromosomal translocation in hematopoietic stem or early
143 typically 20 to 600 bp in size) are prone to chromosomal translocation in lymphomas.
144 s created by the recurrent t(11;18)(q21;q21) chromosomal translocation in mucosa-associated lymphoid
145 as a proto-oncogene resulting from a t(6;14) chromosomal translocation in multiple myeloma and its ex
146                   Here we report a recurrent chromosomal translocation in SNS, t(2;4)(q35;q31.1), res
147 asked whether PARP1 inhibition could prevent chromosomal translocations in 3 translocation reporter s
148 disposes to thymic lymphomas associated with chromosomal translocations in a p53 mutant background, a
149 anscription factor, is overexpressed through chromosomal translocations in a subset of B cell lymphom
150 rand breaks, inverted duplications and intra-chromosomal translocations in a wide spectrum of organis
151                            Recent studies of chromosomal translocations in activated B lymphocytes ha
152 transcription factor is converted by t(1;19) chromosomal translocations in acute leukemia into the ch
153 ation genes (MTGs), originally identified as chromosomal translocations in acute myelogenous leukemia
154 MTG16 (CBFA2T3) are identified as targets of chromosomal translocations in acute myeloid leukemia (AM
155 enetic links to cancer with the discovery of chromosomal translocations in association with many hema
156                    Despite their rarity, IGH chromosomal translocations in BCP-ALL therefore define n
157       Hi-C data can also be used to validate chromosomal translocations in cancer genomes.
158 g small indels as well as long deletions and chromosomal translocations in future versions.
159 cr, which may be important for generation of chromosomal translocations in humans.
160  advances toward understanding the origin of chromosomal translocations in incipient lymphoid cancers
161                             The discovery of chromosomal translocations in leukemia/lymphoma and sarc
162 t for the formation of the most common human chromosomal translocations in lymphoid malignancies, yet
163 ome non-consensus RSS, frequently present at chromosomal translocations in lymphoid neoplasms, may pr
164 eukemia-2) discovered via its involvement in chromosomal translocations in lymphomas.
165  the product of a proto-oncogene involved in chromosomal translocations in multiple myeloma.
166                                              Chromosomal translocations in nodular fasciitis result i
167        The biological outcome of TMPRSS2:ERG chromosomal translocations in prostate cancer (PC) remai
168 wn as EVI1) proto-oncogene is deregulated by chromosomal translocations in some cases of acute myeloi
169                      LMO2 was discovered via chromosomal translocations in T-cell leukaemia and shown
170                          LMO2 is a target of chromosomal translocations in T-cell tumors and was acti
171          Expression profiling has shown that chromosomal translocations, in particular, are associate
172 ther V(D)J recombination or CSR can initiate chromosomal translocations, including oncogenic IgH locu
173 genomic instability has been associated with chromosomal translocations, including the recurrent t(11
174 o an oncoantigen resulting from an oncogenic chromosomal translocation inhibits lymphoma disseminatio
175      A variety of genetic lesions, including chromosomal translocations, internal tandem duplications
176 cells express oncogenic ALK resulting from a chromosomal translocation involved in lymphomagenesis.
177  factor 1 (CSF1), and is usually caused by a chromosomal translocation involving CSF1.
178 ymphoid malignancies characterized by clonal chromosomal translocations involving antigen receptor ge
179                                              Chromosomal translocations involving antigen receptor lo
180                                     Finally, chromosomal translocations involving chromatin regulator
181  alterations of GNA13, CREBBP, and EZH2, and chromosomal translocations involving IgH and either BCL2
182 ator of normal hematopoietic development and chromosomal translocations involving MLL are one of the
183 xpression in leukemic cells, suggesting that chromosomal translocations involving MLL could lead to t
184                                              Chromosomal translocations involving the ERG locus are f
185                                              Chromosomal translocations involving the immunoglobulin
186                                              Chromosomal translocations involving the MALT1 gene are
187                                     AML with chromosomal translocations involving the mixed lineage l
188                                    Recurrent chromosomal translocations involving the mixed lineage l
189                                              Chromosomal translocations involving the Mixed Lineage L
190                                              Chromosomal translocations involving the MLL gene are as
191 subset of acute myeloid leukemias (AML) with chromosomal translocations involving the MLL gene have a
192                                              Chromosomal translocations involving the NTRK1, NTRK2, a
193                                              Chromosomal translocations involving the Nup98 gene are
194 y harbored RAG-dependent reciprocal t(14:15) chromosomal translocations involving the T cell receptor
195                                              Chromosomal translocations involving the TCR loci repres
196                                              Chromosomal translocations involving transcription facto
197 ytosis, has been identified in two recurring chromosomal translocations, involving either MLL or MLLT
198                                              Chromosomal translocation is the most common form of chr
199 al organization of the genome contributes to chromosomal translocations is an important question in c
200 rors in CSR can lead to dangerous, oncogenic chromosomal translocations it is important to identify t
201                                              Chromosomal translocations juxtaposing the androgen-resp
202                                              Chromosomal translocations leading to deregulated expres
203  is a plasma cell blood cancer with frequent chromosomal translocations leading to gene fusions.
204  gene expression and is a frequent target of chromosomal translocations leading to leukemia.
205 is a member of the nuclear pore complex, the chromosomal translocations leading to NUP98 gene fusions
206                            Due to reciprocal chromosomal translocations, many species of Oenothera (e
207  are frequently altered in leukaemia through chromosomal translocation, mutation or aberrant expressi
208                                            A chromosomal translocation observed in the majority of hu
209     In this regard, major RAG off-targets in chromosomal translocations occur as convergent RSS pairs
210 dominant-negative truncation that models the chromosomal translocation of human DISC1 in schizophreni
211 rying both a deletion of FcgammaRIIB and the chromosomal translocation of Y-linked autoimmune acceler
212 ) is frequently associated with mutations or chromosomal translocations of genes encoding transcripti
213 g of cells that have acquired cancer-causing chromosomal translocations of great relevance for humans
214                                              Chromosomal translocations of the mixed lineage leukemia
215                                              Chromosomal translocations of the Mixed-lineage leukemia
216                                              Chromosomal translocations of the mixed-lineage leukemia
217 sive subset of human acute leukemia carrying chromosomal translocations of the MLL gene.
218 ns and targeted somatic engineering of inter-chromosomal translocations, offering multifaceted opport
219 etically altered by mutation, amplification, chromosomal translocation or inversion, has been shown t
220                         We hypothesized that chromosomal translocations or complex karyotypes and dis
221 sing proteins, such as those expressed after chromosomal translocations or from point mutations, are
222 ia (MLL) gene is also frequently involved in chromosomal translocations or partial tandem duplication
223       Activation of Janus kinase 2 (JAK2) by chromosomal translocations or point mutations is a frequ
224 ally as a consequence of gene amplification, chromosomal translocations, or posttranslational mechani
225 actors are commonly deregulated in cancer by chromosomal translocation, overexpression or post-transl
226                           MLL is involved in chromosomal translocations, partial tandem duplications,
227 hronic phase, this sole genetic abnormality (chromosomal translocation Ph(+): t(9;22)(q34;q11)) at th
228 cluding castration resistance and subsequent chromosomal translocations, play key roles in prostate c
229  expression, transcriptional activity, or by chromosomal translocation plays a critical role in carci
230 actor complex that is frequently involved in chromosomal translocations, point mutations, or deletion
231                                    Recurrent chromosomal translocations producing a chimaeric MLL onc
232                                    Oncogenic chromosomal translocations provide cells with a prolifer
233                                              Chromosomal translocations represent frequent events in
234 or protein tyrosine kinase, is involved in a chromosomal translocation resulting in expression of a B
235 MLL1 gene is a frequent target for recurrent chromosomal translocations, resulting in transformation
236  several recent reports, we demonstrate that chromosomal translocation risk is causally unrelated to
237 te lymphoblastic leukemia (ALL), the t(1,19) chromosomal translocation specifically targets the E2A g
238 e location of genes involved in carcinogenic chromosomal translocations, suggesting their role in can
239                 Here we demonstrate that the chromosomal translocation t(10;12)(q26;q12) leading to F
240                  The genetic hallmark is the chromosomal translocation t(11;14) resulting in aberrant
241 AML2 fusion oncogene, encoded by a recurring chromosomal translocation t(11;19)(q14-21;p12-13), is a
242 g sarcomas are characterized by the in-frame chromosomal translocation t(11;22) generating the EWS-FL
243 FLI1 is a fusion gene product generated by a chromosomal translocation t(11;22)(q24;q12) found in Ewi
244 E2A-PBX1 fusion oncogene, which results from chromosomal translocation t(1;19) and is present in 5% t
245                                          The chromosomal translocation t(2;11)(p21;q23) found in pati
246 e fusion protein NUP98-HOXD13 (NHD13) of the chromosomal translocation t(2;11)(q31;p15) is expressed
247 th acute myeloid leukemia characterized by a chromosomal translocation t(7;12)-HLXB9/TEL and concomit
248  skin tumor associated with a characteristic chromosomal translocation (t[17;22][q22;q13]) resulting
249 ients, 2 of which were associated with known chromosomal translocations (t(1;19)(TCF3-PBX1) or MLL),
250 y identified at the breakpoint of a balanced chromosomal translocation, t(1;11) (q42.1;14.3), in a fa
251 illness through its disruption by a balanced chromosomal translocation, t(1;11)(q42.1;q14.3), that co
252                                              Chromosomal translocations targeting the mixed lineage l
253                                 The t(12;21) chromosomal translocation, targeting the gene encoding t
254  acute myeloid leukemias (AMLs), a recurring chromosomal translocation, termed t(8;21), generates the
255 are 100- to 1,000-fold more prone to undergo chromosomal translocation than the adjacent regions.
256 (PML) was originally identified as part of a chromosomal translocation that contributes to the develo
257  is characterized by the t(15;17)(q22;q11.2) chromosomal translocation that creates the promyelocytic
258  hypotonia that harbored a de novo, balanced chromosomal translocation that disrupts the CAPZB gene.
259 Ewing's sarcoma contain the (11;22)(q24;q12) chromosomal translocation that encodes the EWS/FLI oncop
260 hyroid carcinomas contains a t(2;3)(q13;p25) chromosomal translocation that fuses paired box gene 8 (
261 3 gene cause Waardenburg syndrome, whereas a chromosomal translocation that generates a PAX3-FOXO1 fu
262 oft tissue malignancy initiated by a t(X;18) chromosomal translocation that generates an SS18-SSX fus
263  sarcoma is characterized by a pathognomonic chromosomal translocation that generates the EWSR1-FLI1
264 ), an indolent neoplasm caused by a t(14;18) chromosomal translocation that juxtaposes the BCL2 gene
265 ALL) harbor a fusion oncogene results from a chromosomal translocation that juxtaposes the mixed-line
266                                          The chromosomal translocation that leads to alveolar rhabdom
267  cells, BCR expression is retained despite a chromosomal translocation that links the antiapoptotic g
268 osarcoma is characterized by a pathognomonic chromosomal translocation that results in an oncogenic f
269                                              Chromosomal translocation that results in fusion of the
270                       Driven by an oncogenic chromosomal translocation that results in the expression
271                  It is caused by the t(9;22) chromosomal translocation that results in the expression
272 EJ) in the generation of large deletions and chromosomal translocations that are frequently observed
273 xpressed at the transcriptional level due to chromosomal translocations that bring the MYC gene under
274  but improper regulation of DSBs can lead to chromosomal translocations that can result in B cell lym
275 he MLL gene is involved in a large number of chromosomal translocations that create chimeric proteins
276 K expression in nonneural cells results from chromosomal translocations that create novel fusion prot
277                 Most Ewing's sarcomas harbor chromosomal translocations that encode fusions between E
278 ; 3 of 97 tumors examined) harbors oncogenic chromosomal translocations that fuse in-frame the tyrosi
279 promyelocytic leukemia is causally linked to chromosomal translocations that generate chimeric retino
280                Most ARMS are associated with chromosomal translocations that have breakpoints in intr
281                                              Chromosomal translocations that juxtapose the androgen-s
282 l carcinomas (TFE-fusion RCCs) are caused by chromosomal translocations that lead to overexpression o
283  Ewing sarcoma family tumors (ESFTs) exhibit chromosomal translocations that lead to the creation of
284 vere forms of DNA damage and responsible for chromosomal translocations that may lead to gene fusions
285                  Breakpoint junctions of the chromosomal translocations that occur in human cancers d
286 acterized by simple karyotypes and recurrent chromosomal translocations, the mechanisms driving cytog
287 this approach in three patients with complex chromosomal translocations: The first had craniofacial a
288                                Using induced chromosomal translocation to pair barcodes representing
289                                          IgH chromosomal translocations to the c-myc oncogene also ar
290 at allows large-scale abnormalities, such as chromosomal translocations, to be identified.
291                                 The t(14;18) chromosomal translocation typically involves breakage at
292                                    Recurrent chromosomal translocations underlie both haematopoietic
293 eover, a BCAM-AKT2 fusion gene generated via chromosomal translocation using the CRISPR/Cas9 system l
294  AML1 function and its direct involvement in chromosomal translocation, we demonstrate that both the
295                                              Chromosomal translocations were detected in 12 of the 64
296                                     Although chromosomal translocations were detected, the frequency
297                                              Chromosomal translocations were high.
298 , NTRK3, and RET gene fusions resulting from chromosomal translocations were identified.
299 ces the risk for aberrant recombinations and chromosomal translocations when exposed to DNA damage, i
300  promyelocytic leukemia (APL) is driven by a chromosomal translocation whose product, the PML/retinoi

 
Page Top